With New Kind of CAR, Cancer Startup Cargo Refuels With $200M for Cell Therapy Race
Patients whose blood cancer advances after initial treatments have one last therapeutic option: the engineering of their immune cells into a living medicine. But cancer is crafty and it often finds a way to…
Continue Reading